Author:
Zidan Ahmed S.,Spinks Crystal,Fortunak Joseph,Habib Muhammad,Khan Mansoor A.
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Clumeck N, De Wit S. Update on highly active antiretroviral therapy: progress and strategies. Biomed Pharmacother. 2000;54:7–12.
2. Kaufmann GR, Cooper GA. Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options. Curr Opin Microbiol. 2000;3:508–14.
3. Cihlar T, Birkus G, Greenwalt DE, Hitchcock MJM. Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors. Antiviral Res. 2002;54(1):37–45.
4. Cihlar T, Bischofberger N. PMEA and PMPA: acyclic nucleoside phosphonates with potent anti-HIV activity. In: Van der Goot H, editor. Trends in drug research II. Amsterdam: Elsevier; 1998. p. 105–16.
5. Schooley R, Myers R, Ruane P, Beall G, Lampiris H, Miller M, Mills R, McGowan I. Tenofovir disoproxil fumarate (TDF) for the treatment of antiretroviral experienced patients. A double-blind placebo-controlled study. 40th International Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada; 2000.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献